(19)
(11) EP 1 989 185 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
26.06.2013 Bulletin 2013/26

(45) Mention of the grant of the patent:
22.05.2013 Bulletin 2013/21

(21) Application number: 07751888.4

(22) Date of filing: 27.02.2007
(51) International Patent Classification (IPC): 
C07D 231/14(2006.01)
C07D 409/04(2006.01)
C07D 417/14(2006.01)
C07D 453/04(2006.01)
A61P 25/28(2006.01)
 C07D 401/04(2006.01)
C07D 409/14(2006.01)
C07D 451/06(2006.01)
A61K 31/4155(2006.01)
(86) International application number:
PCT/US2007/005157
(87) International publication number:
WO 2007/100851 (07.09.2007 Gazette 2007/36)

(54)

THERAPEUTIC COMPOUNDS

THERAPEUTISCHE VERBINDUNGEN

COMPOSES THERAPEUTIQUES

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

(30) Priority: 28.02.2006 US 777332 P
16.02.2007 US 890455 P

(43) Date of publication of application:
12.11.2008 Bulletin 2008/46

(60) Divisional application:
11184196.1 / 2465850

(73) Proprietor: Dart NeuroScience LLC
San Diego, CA 92121 (US)

(72) Inventors:
  • ZHOU, Xianbo
    Ridgefield, CT 06877 (US)
  • SCOTT, Roderick, E.M.
    Poway, CA 02964 (US)
  • BOURTCHOULADZE, Rusiko
    New York, NY 10033 (US)
  • KAPLAN, Alan, P.
    Kings Park, NY 11754 (US)
  • KEENAN, Terence, P.
    Bay Shore, NY 11706 (US)
  • MCRINER, Andrew
    Melrose, MA 02176 (US)

(74) Representative: Kirkham, Nicholas Andrew 
Graham Watt & Co. LLP St. Botolph's House 7-9 St. Botolph's Road
Sevenoaks, Kent TN13 3AJ
Sevenoaks, Kent TN13 3AJ (GB)


(56) References cited: : 
EP-A1- 1 024 138
WO-A-2006/046916
WO-A-2007/030574
US-A- 5 204 482
 WO-A-2004/013130
WO-A-2007/002559
WO-A1-2004/060882
US-A1- 2006 041 006
   
     
    Remarks:
    The file contains technical information submitted after the application was filed and not included in this specification
     
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).